Annual Drug Patent Expirations for ZYDELIG
Zydelig is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
This drug has one hundred and forty-eight patent family members in forty-seven countries.
The generic ingredient in ZYDELIG is idelalisib. One supplier is listed for this compound. Additional details are available on the idelalisib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
